.png)
Controlled Release Drug Delivery Market By Technology, Mechanism and Application - Global Industry Analysis And Forecast To 2027
Published On : October 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC101461
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Controlled Release Drug Delivery Market By Technology (Targeted Delivery, Wurster Technique, Transdermal, Coacervation, Implants, Micro Encapsulation and Other Technologies), Mechanism (Chemically Activated Drug Delivery Systems, Polymer Based Systems Drug Delivery Systems, Activation-modulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems and Feedback Regulated Drug Delivery Systems) and Application (Drug Eluting Stents, Metered Dose Inhalers, Oral Controlled-Drug Delivery Systems, Injectable, Infusion Pumps and Transdermal & Ocular Patches)- Global Industry Analysis And Forecast To 2027
Industry Outlook
The controlled drug delivery is the one procedure that conveys the medication at a pre-decided rate, for systemically or locally, for a predefined timeframe. The consistent oral conveyance of medications at reproducible and predictable energy for foreseen time period over the span of GIT. The controlled drug delivery conveyance utilizes the gadgets of drug-encapsulation from which helpful therapeutic agents might be discharged at controlled rates for extensive stretches of time, extending from days to months. These systems offer various preferences over conventional strategies for medication conveyance, which include the tailoring of rates of medication discharge, security of delicate drugs and expanded patient solace and consistence. Therefore, the Controlled Release Drug Delivery Market is anticipated to expand and has tremendous scope during the forecast period. The global Controlled Release Drug Delivery Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
On the basis of Technology the market is further divided into Targeted Delivery, Wurster Technique, Transdermal, Coacervation, Implants, Micro Encapsulation and Other Technologies. The section Targeted Delivery is dominating the market due to a strong background in the market.
On the basis of Mechanism the market is further divided into Chemically Activated Drug Delivery Systems, Polymer Based Systems Drug Delivery Systems, Activation-modulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems and Feedback Regulated Drug Delivery Systems. The section Polymer Based Systems Drug Delivery Systems is leading the market due to their capability of spatial & controlled release of the loaded therapeutics.
On the basis of Mechanism the market is further divided into Drug Eluting Stents, Metered Dose Inhalers, Oral Controlled-Drug Delivery Systems, Injectable, Infusion Pumps and Transdermal & Ocular Patches. The Oral Controlled-Drug Delivery Systems section is leading the market due to easy availability & more frequent utilization.
Regional Insights
The North American region is dominating the global Controlled Release Drug Delivery Market owing to factor like; increasing initiatives by the government that are proving supportive to development of the drugs, rising investment on the R&D related to the drugs, etc.
Controlled Release Drug Delivery Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Capsugel
- Orbis Biosciences Inc.
- Aradigm Corporation
- Corium International Inc.
- Merck and Co. Inc.
- Pfizer Inc.
- Alkermes plc
- Depomed Inc.
- Johnson and Johnson
- Coating Place Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Controlled Release Drug Delivery Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
o Targeted Delivery
o Wurster Technique
o Transdermal
o Coacervation
o Implants
o Micro Encapsulation
o Other Technologies
o Controlled Release Drug Delivery Market, By Mechanism, Estimates and Forecast, 2017-2027 ($Million)
o Chemically Activated Drug Delivery Systems
o Polymer Based Systems Drug Delivery Systems
o Activation-modulated Drug Delivery Systems
o Micro Reservoir Partition Controlled Drug Delivery Systems
o Feedback Regulated Drug Delivery Systems
o Controlled Release Drug Delivery Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Drug Eluting Stents
o Metered Dose Inhalers
o Oral Controlled-Drug Delivery Systems
o Injectable
o Infusion Pumps
o Transdermal & Ocular Patches
o Controlled Release Drug Delivery Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Controlled Release Drug Delivery Market, By Country
o U.S. Controlled Release Drug Delivery Market
o Canada Controlled Release Drug Delivery Market
o Mexico Controlled Release Drug Delivery Market
o Europe
§ Europe Controlled Release Drug Delivery Market, By Country
o Germany Controlled Release Drug Delivery Market
o UK Controlled Release Drug Delivery Market
o France Controlled Release Drug Delivery Market
o Russia Controlled Release Drug Delivery Market
o Italy Controlled Release Drug Delivery Market
o Rest of Europe Controlled Release Drug Delivery Market
o Asia-Pacific
§ Asia-Pacific Controlled Release Drug Delivery Market, By Country
o China Controlled Release Drug Delivery Market
o Japan Controlled Release Drug Delivery Market
o South Korea Controlled Release Drug Delivery Market
o India Controlled Release Drug Delivery Market
o Southeast Asia Controlled Release Drug Delivery Market
o Rest of Asia-Pacific Controlled Release Drug Delivery Market
o South America
§ South America Controlled Release Drug Delivery Market, By Country
o Brazil Controlled Release Drug Delivery Market
o Argentina Controlled Release Drug Delivery Market
o Columbia Controlled Release Drug Delivery Market
o Rest of South America Controlled Release Drug Delivery Market
o Middle East and Africa
§ Middle East and Africa Controlled Release Drug Delivery Market, By Country
o Saudi Arabia Controlled Release Drug Delivery Market
o UAE Controlled Release Drug Delivery Market
o Egypt Controlled Release Drug Delivery Market
o Nigeria Controlled Release Drug Delivery Market
o South Africa Controlled Release Drug Delivery Market
o Rest of MEA Controlled Release Drug Delivery Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Controlled Release Drug Delivery Market, By Technology
5.1. Introduction
5.2. Global Controlled Release Drug Delivery Revenue and Market Share by Technology (2017-2027)
5.2.1. Global Controlled Release Drug Delivery Revenue and Revenue Share by Technology (2017-2027)
5.3. Targeted Delivery
5.3.1. Global Targeted Delivery Revenue and Growth Rate (2017-2027)
5.4. Wurster Technique
5.4.1. Global Wurster Technique Revenue and Growth Rate (2017-2027)
5.5. Transdermal
5.5.1. Global Transdermal Revenue and Growth Rate (2017-2027)
5.6. Coacervation
5.6.1. Global Coacervation Revenue and Growth Rate (2017-2027)
5.7. Implants
5.7.1. Global Implants Revenue and Growth Rate (2017-2027)
5.8. Micro Encapsulation
5.8.1. Global Micro Encapsulation Revenue and Growth Rate (2017-2027)
5.9. Other Technologies
5.9.1. Global Other Technologies Revenue and Growth Rate (2017-2027)
6. Controlled Release Drug Delivery Market, By Mechanism
6.1. Introduction
6.2. Global Controlled Release Drug Delivery Revenue and Market Share by Mechanism (2017-2027)
6.2.1. Global Controlled Release Drug Delivery Revenue and Revenue Share by Mechanism (2017-2027)
6.3. Chemically Activated Drug Delivery Systems
6.3.1. Global Chemically Activated Drug Delivery Systems Revenue and Growth Rate (2017-2027)
6.4. Polymer Based Systems Drug Delivery Systems
6.4.1. Global Polymer Based Systems Drug Delivery Systems Revenue and Growth Rate (2017-2027)
6.5. Activation-modulated Drug Delivery Systems
6.5.1. Global Activation-modulated Drug Delivery Systems Revenue and Growth Rate (2017-2027)
6.6. Micro Reservoir Partition Controlled Drug Delivery Systems
6.6.1. Global Micro Reservoir Partition Controlled Drug Delivery Systems Revenue and Growth Rate (2017-2027)
6.7. Feedback Regulated Drug Delivery Systems
6.7.1. Global Feedback Regulated Drug Delivery Systems Revenue and Growth Rate (2017-2027)
7. Controlled Release Drug Delivery Market, By Application
7.1. Introduction
7.2. Global Controlled Release Drug Delivery Revenue and Market Share by Application (2017-2027)
7.2.1. Global Controlled Release Drug Delivery Revenue and Revenue Share by Application (2017-2027)
7.3. Drug Eluting Stents
7.3.1. Global Drug Eluting Stents Revenue and Growth Rate (2017-2027)
7.4. Metered Dose Inhalers
7.4.1. Global Metered Dose Inhalers Revenue and Growth Rate (2017-2027)
7.5. Oral Controlled-Drug Delivery Systems
7.5.1. Global Oral Controlled-Drug Delivery Systems Revenue and Growth Rate (2017-2027)
7.6. Injectable
7.6.1. Global Injectable Revenue and Growth Rate (2017-2027)
7.7. Infusion Pumps
7.7.1. Global Infusion Pumps Revenue and Growth Rate (2017-2027)
7.8. Transdermal & Ocular Patches
7.8.1. Global Transdermal & Ocular Patches Revenue and Growth Rate (2017-2027)
8. Controlled Release Drug Delivery Market, By Region
8.1. Introduction
8.2. Global Controlled Release Drug Delivery Revenue and Market Share by Regions
8.2.1. Global Controlled Release Drug Delivery Revenue by Regions (2017-2027)
8.3. North America Controlled Release Drug Delivery by Countries
8.3.1. North America Controlled Release Drug Delivery Revenue and Growth Rate (2017-2027)
8.3.2. North America Controlled Release Drug Delivery Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Controlled Release Drug Delivery by Countries
8.4.1. Europe Controlled Release Drug Delivery Revenue and Growth Rate (2017-2027)
8.4.2. Europe Controlled Release Drug Delivery Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Controlled Release Drug Delivery by Countries
8.5.1. Asia-Pacific Controlled Release Drug Delivery Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Controlled Release Drug Delivery Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Controlled Release Drug Delivery by Countries
8.6.1. South America Controlled Release Drug Delivery Revenue and Growth Rate (2017-2027)
8.6.2. South America Controlled Release Drug Delivery Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Controlled Release Drug Delivery by Countries
8.7.1. Middle East and Africa Controlled Release Drug Delivery Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Controlled Release Drug Delivery Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Capsugel
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Orbis Biosciences Inc.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Aradigm Corporation
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Corium International Inc.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Merck and Co. Inc.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Pfizer Inc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Alkermes plc
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Depomed Inc.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Johnson and Johnson
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. Coating Place Inc.
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
10. Global Controlled Release Drug Delivery Market Competition, by Manufacturer
10.1. Global Controlled Release Drug Delivery Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Controlled Release Drug Delivery Price By Region (2017-2017)
10.3. Top 5 Controlled Release Drug Delivery Manufacturer Market Share
10.4. Market Competition Trend
11. Controlled Release Drug Delivery Market Forecast (2017-2027)
11.1. Global Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Controlled Release Drug Delivery Market Forecast by Regions (2017-2027)
11.2.1. North America Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.1.1. United States Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.1.2. Canada Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.1.3. Mexico Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.2. Europe Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.2.1. Germany Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.2.2. France Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.2.3. UK Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.2.4. Russia Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.2.5. Italy Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.3. Asia-Pacific Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.3.1. China Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.3.2. Japan Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.3.3. Korea Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.3.4. India Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.4. South America Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.4.1. Brazil Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.4.2. Argentina Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.4.3. Columbia Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.4.4. Rest of South America Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.5. Middle East and Africa Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.5.3. Egypt Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.5.4. Nigeria Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.5.5. South Africa Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.5.6. Turkey Controlled Release Drug Delivery Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Controlled Release Drug Delivery Market Forecast (2017-2027)
11.3. Controlled Release Drug Delivery Market Forecast by Technology (2017-2027)
11.3.1. Controlled Release Drug Delivery Forecast by Technology (2017-2027)
11.3.2. Controlled Release Drug Delivery Market Share Forecast by Technology (2017-2027)
11.4. Controlled Release Drug Delivery Market Forecast by Mechanism (2017-2027)
11.4.1. Controlled Release Drug Delivery Forecast by Mechanism (2017-2027)
11.4.2. Controlled Release Drug Delivery Market Share Forecast by Mechanism (2017-2027)
11.5. Controlled Release Drug Delivery Market Forecast by Application (2017-2027)
11.5.1. Controlled Release Drug Delivery Forecast by Application (2017-2027)
11.5.2. Controlled Release Drug Delivery Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Controlled Release Drug Delivery Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Controlled Release Drug Delivery Revenue and Revenue Share by Technology (2017-2018)
Figure Global Targeted Delivery Revenue and Growth Rate (2017-2018)
Figure Global Wurster Technique Revenue and Growth Rate (2017-2018)
Figure Global Transdermal Revenue and Growth Rate (2017-2018)
Figure Global Coacervation Revenue and Growth Rate (2017-2018)
Figure Global Implants Revenue and Growth Rate (2017-2018)
Figure Global Micro Encapsulation Revenue and Growth Rate (2017-2018)
Figure Global Other Technologies Revenue and Growth Rate (2017-2018)
Table Global Controlled Release Drug Delivery Revenue and Revenue Share by Mechanism (2017-2018)
Figure Global Chemically Activated Drug Delivery Systems Revenue and Growth Rate (2017-2018)
Figure Global Polymer Based Systems Drug Delivery Systems Revenue and Growth Rate (2017-2018)
Figure Global Activation-modulated Drug Delivery Systems Revenue and Growth Rate (2017-2018)
Figure Global Micro Reservoir Partition Controlled Drug Delivery Systems Revenue and Growth Rate (2017-2018)
Figure Global Feedback Regulated Drug Delivery Systems Revenue and Growth Rate (2017-2018)
Table Global Controlled Release Drug Delivery Revenue and Revenue Share by Application (2017-2018)
Figure Global Drug Eluting Stents Revenue and Growth Rate (2017-2018)
Figure Global Metered Dose Inhalers Revenue and Growth Rate (2017-2018)
Figure Global Oral Controlled-Drug Delivery Systems Revenue and Growth Rate (2017-2018)
Figure Global Injectable Revenue and Growth Rate (2017-2018)
Figure Global Infusion Pumps Revenue and Growth Rate (2017-2018)
Figure Global Transdermal & Ocular Patches Revenue and Growth Rate (2017-2018)
Table Global Controlled Release Drug Delivery Revenue by Regions (2017-2018)
Figure North America Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure North America Controlled Release Drug Delivery Revenue and Growth Rate (2017-2018)
Figure North America Controlled Release Drug Delivery by Countries (2017-2018)
Figure North America Controlled Release Drug Delivery Revenue (Million USD) by Countries (2017-2018)
Figure United States Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure United States Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Canada Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Mexico Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Europe Controlled Release Drug Delivery Revenue and Growth Rate (2017-2018)
Figure Europe Controlled Release Drug Delivery by Countries (2017-2018)
Figure Europe Controlled Release Drug Delivery Revenue (Million USD) by Countries (2017-2018)
Figure Germany Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Germany Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure France Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure UK Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Russia Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Italy Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Rest of Europe Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Asia-Pacific Controlled Release Drug Delivery Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Controlled Release Drug Delivery by Countries (2017-2018)
Figure Asia-Pacific Controlled Release Drug Delivery Revenue (Million USD) by Countries (2017-2018)
Figure China Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure China Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Japan Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Korea Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure India Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Southeast Asia Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure South America Controlled Release Drug Delivery Revenue and Growth Rate (2017-2018)
Figure South America Controlled Release Drug Delivery by Countries (2017-2018)
Figure South America Controlled Release Drug Delivery Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Brazil Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Argentina Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Columbia Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Rest of South America Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Middle East and Africa Controlled Release Drug Delivery Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Controlled Release Drug Delivery by Countries (2017-2018)
Figure Middle East and Africa Controlled Release Drug Delivery Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Saudi Arabia Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure United Arab Emirates Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Egypt Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Nigeria Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure South Africa Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Turkey Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Controlled Release Drug Delivery Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2017-2018)
Table Capsugel Controlled Release Drug Delivery Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Orbis Biosciences Inc. Controlled Release Drug Delivery Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Aradigm Corporation Controlled Release Drug Delivery Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Corium International Inc. Controlled Release Drug Delivery Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck and Co. Inc. Controlled Release Drug Delivery Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Controlled Release Drug Delivery Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Alkermes plc Controlled Release Drug Delivery Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Depomed Inc. Controlled Release Drug Delivery Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Johnson and Johnson Controlled Release Drug Delivery Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Coating Place Inc. Controlled Release Drug Delivery Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Controlled Release Drug Delivery Market Share by Manufacturer
Figure Global Controlled Release Drug Delivery Revenue and Market Share by Manufacturer
Table Global Controlled Release Drug Delivery Price by Region (2017-2017)
Figure Top 5 Controlled Release Drug Delivery Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Controlled Release Drug Delivery Revenue (Millions USD) and Growth Rate (2018-2025)
Table Controlled Release Drug Delivery Market Forecast by Regions (2018-2025)
Figure North America Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure United States Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Canada Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Mexico Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Europe Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Germany Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure France Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure UK Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Russia Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Italy Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Rest of Europe Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Asia-Pacific Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure China Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Japan Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Korea Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure India Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Southeast Asia Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure South America Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Brazil Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Argentina Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Columbia Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Rest of South America Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Middle East and Africa Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Saudi Arabia Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure United Arab Emirates Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Egypt Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Nigeria Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure South Africa Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Turkey Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Controlled Release Drug Delivery Market Forecast (2018-2025)
Figure Global Controlled Release Drug Delivery Forecast by Technology (2018-2025)
Figure Global Controlled Release Drug Delivery Market Share Forecast by Technology (2018-2025)
Figure Global Controlled Release Drug Delivery Forecast by Technology (2018-2025)
Figure Global Controlled Release Drug Delivery Forecast by Mechanism (2018-2025)
Figure Global Controlled Release Drug Delivery Market Share Forecast by Mechanism (2018-2025)
Figure Global Controlled Release Drug Delivery Forecast by Mechanism (2018-2025)
Figure Global Controlled Release Drug Delivery Forecast by Application (2018-2025)
Figure Global Controlled Release Drug Delivery Market Share Forecast by Application (2018-2025)
Figure Global Controlled Release Drug Delivery Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|